Pharmacology Watch – June 1, 2016
June 1, 2016
View Issues
-
Review of Antibiotic Prescriptions Reignites Call for More Stewardship Programs
About one-third of outpatient antibiotic prescriptions may be inappropriate, according to a new study.
-
Study Scrutinizes Smoking Cessation Drug Risk
The neuropsychiatric risks of smoking cessation drugs may have been overstated, according to an FDA-requested study.
-
Clinical Brief Notes
Researchers make progress on Ebola vaccine and diabetes treatments.
-
FDA Actions
Agency approves first biosimilar for infliximab, issues warning about Abilify, announces brand name change for Brintellix, greenlights pimavanserin, and brings to market first generic version of rosuvastatin.